ABCB1 and ERCC1 gene polymorphisms are associated with nephro- and hepatotoxicity to carboplatin/paclitaxel-based chemotherapy in patients with gynecologic cancers
ConclusionsABCB1 c.1236C>T andERCC1 c.118C>T might serve as potential biomarkers for the risk of moderate-to-severe toxicities to carboplatin/paclitaxel chemotherapy of gynecological cancers.
Source: European Journal of Clinical Pharmacology - Category: Drugs & Pharmacology Source Type: research
More News: Brazil Health | Cancer | Cancer & Oncology | Chemotherapy | Diabetes | Drugs & Pharmacology | Electronic Medical Records (EMR) | Endocrinology | Genetics | Toxicology